Skip to ContentSkip to Navigation
Over onsFaculty of Science and EngineeringOnderzoekGRIPPharmacoTherapy, -Epidemiology & -Economics (PTEE)Publications

Publications 2017

Below our publications are listed using several headings. Scientific publications relate to original research, often published internationally, but also in the Dutch language. Professional publications are in Dutch and relate to reviews and expressions of opinions.

Scientific publication international
Aardema H, Nannan Panday P, Wessels M, van Hateren K, Dieperink W, Kosterink JGW, Alffenaar JW, Zijlstra JG. Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study. Int J Antimicrob Agents. 2017 May 10. pii: S0924-8579(17)30147-4. doi: 10.1016/j.ijantimicag.2017.02.020. [Epub ahead of print]
Arifin B, Perwitasari DA, at Thobari JA, Cao Q, Krabbe PFM, Postma MJ. Translation, Revision, and Validation of the Diabetes Distress Scale for Indonesian Type 2 Diabetic Outpatients with Various Types of Complications. Value in Health Regional Issues 2017;12: 63-73
Bachmann CJ, Wijlaars LP, Kalverdijk L, Burcu M, Glaeske G, Schuiling-Veninga CCM, Hoffmann F, Aagaard L, Zito JM.Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012. European Neuropsychopharmacology. 2017. Available from, DOI: 10.1016/j.euroneuro.2017.03.002
Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, Coma Fusté A, Furu K, Garuoliené K, Hoffmann F, Hollingworth S, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Piovani D, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Siskind D, Skurtveit S, Verdoux H, Wang LJ, Zara Yahni C, Zoëga H, Taylor D. International trends in clozapine use: a study in 17 countries. Acta Psychiatr Scand. 2017 May 14. doi: 10.1111/acps.12742. [Epub ahead of print]
Bahar MA, Hak E, Bos JHJ, Borgsteede SD, Wilffert B. The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly. Pharmcoepidemiology and Drug Safety. 2017. Available from, DOI: 10.1002/pds.4200
Bahar MA, Setiawan D, Hak E, Wilffert B. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6. Pharmacogenomics. 2017; 18(7):701-39
Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens, AFA, Loonen AJM. The role of the habenula in the transition from reward to misery in substance use and mood disorders. Neuroscience and Biobehavioral Reviews 2017;80:276-85
Bate A, Beckmann J, Dodoo A, Härmark L, Hartigan-Go K, Hegerius A, Lindquist M, van Puijenbroek E, Tuccori M, Hagemann U. Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery. Drug Safety. 2017 Jan 18;1-9. Available from, DOI: 10.1007/s40264-016-0495-9
Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mulugeta A, Mengistu YT, Burgerhof JGM, Mol PGM. Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients. British Journal of Clinical Pharmacology. 2017 Apr 21. Available from, DOI: 10.1111/bcp.13312
Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mulugeta A, Mengistu YT, Mol PGM. Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia. BMJ Open 2017 Aug 3;7(8):e015743. doi: 10.1136/bmjopen-2016-015743
Boslooper K, Hoogendoorn M, van Roon EN, Kibbelaar RE, Storm H, Hovenga S, Woolthuis G, van Rees BP, Klijs B, Veeger NJGM, Kluin-Nelemans HC, de Bock GH.No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status. Cancer epidemiology. 2017 Apr 29;48:110-116. Available from, DOI: 10.1016/j.canep.2017.04.009
Broekema AEH, Kuijlen JMA, Lesman-Leegte GAT, Bartels RHMA, van Asselt ADI, Vroomen PCAJ, van Dijk JM, Reneman MF, Soer R, Groen RJ; FACET study group investigators. Study protocol for a randomised controlled multicentre study: the Foraminotomy ACDF Cost-Effectiveness Trial (FACET) in patients with cervical radiculopathy. BMJ Open. 2017 Jan 5;7. e012829. Available from, DOI: 10.1136/bmjopen-2016-012829
Connolly MP, Kotsopoulos N, Postma MJ, Bhatt A. The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care: A Government Perspective Analytic Framework. Value in Health. 2017 Feb;20(2):273-277. Available from, DOI: 10.1016/j.jval.2016.11.018
Darvishian M, van den Heuvel ER, Bissielo A, Castilla J, Cohen C, Englund H,Gefenaite G, Huang WT, la Bastide-van Gemert S, Martinez-Baz I, McAnerney JM, Ntshoe GM, Suzuki M, Turner N, Hak E.Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies. The Lancet. Respiratory Medicine. 2017 Feb 8. Available from, DOI: 10.1016/S2213-2600(17)30043-7
Darvishian M, Dijkstra F, van Doorn E, Bijlsma M, Donker GA, de Lange MMA,Cadenau LM, Hak E, Meijer A.Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes. PLoS ONE. 2017;12(1):e0169528. Available from, DOI: 10.1371/journal.pone.0169528
Daskapan A, Dijkema D, de Weerd A, Bierman WFW, Kosterink JGW, van der Werf TS, Alffenaar JWC, Stienstra Y. Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting. British Journal of Clinical Pharmacology. 2017 DOI: 10.1111/bcp.13366
Daud ANA, Bergman JEH, Oktora MP, Kerstjens-Frederikse WS, Groen H, Bos JH et al.Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies. PLoS ONE. 2017;12(3):e0173530. Available from, DOI: 10.1371/journal.pone.0173530
Daud ANA, Bergsma EL, Bergman JEH, De Walle HEK, Kerstjens-Frederikse WS, Bijker BJ, Hak E, Wilffert B. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research. BMC Pregnancy and Childbirth. 2017 Apr 14;17(1):120. Available from, DOI: 10.1186/s12884-017-1290-z
Daud ANA, Bergman JEH, Kerstjens-Frederikse WS, van der Vlies P, Hak E, Berger RMF, Groen H, Wilffert B. Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study. Pharmacogenomics. 2017 Jul;18(10):987-1001. doi: 10.2217/pgs-2017-0036. Epub 2017 Jun 22
de Boer PT, van Maanen BM, Damm O, Ultsch B, Dolk FCK, Crépey P, Pitman R, Wilschut JC, Postma MJ.A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert review of pharmacoeconomics & outcomes research 2017:1-17. DOI: 10.1080/14737167.2017.1343145
de Jong LA, Dvortsin E, Janssen KJ, Postma MJ.Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands. Clinical Therapeutics. 2017 Jan 28. Available from, DOI: 10.1016/j.clinthera.2016.12.012
de Vries JC, Oortgiesen B, Hemmelder MH, van Roon E, Kibbelaar RE, Veeger N, Hoogendoorn M. Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study. Leukemia and Lymphoma. 2017 Feb 14;1-9. Available from, DOI: 10.1080/10428194.2016.1277385
Dunnewind T, Dvortsin EP, Smeets HM, Konijn RM, Bos JH, de Boer PT, van den Bergh JPW, Postma MJ. Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands. Value in Health 2017;20(6):762-68. DOI: 10.1016/j.jval.2017.02.006
Ekhart C, Matic M, Kant A, van Puijenbroek E, Schaik RV.CYP450 genotype and aggressive behavior on selective serotonin reuptake inhibitors. Pharmacogenomics. 2017. Available from, DOI: 10.2217/pgs-2017-0197
GBD 2016 Mortality Collaborators/Postma MJ. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 390, 10100, p. 1084-150
GBD 2016 Causes of Death Collaborators/Postma MJ. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 390, 10100, p. 1151-210
Granas AG, Stendal Bakken M, Ruths S, Taxis K. Deprescribing for frail older people - Learning from the case of Mrs. Hansen. Res Social Adm Pharm. 2017 Jul 13. pii: S1551-7411(17)30588-0. doi: 10.1016/j.sapharm.2017.07.003. [Epub ahead of print]
Hálfdánarson Ó, Zoëga H, Aagaard L, Bernardo M, Brandt L, Fusté AC, Furu K, Garuoliené K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Skurtveit S, Verdoux H, Wang LJ, Yahni CZ, Bachmann CJ. International trends in antipsychotic use: A study in 16 countries, 2005-2014. Eur Neuropsychopharmacol. 2017 Jul 27. pii: S0924-977X(17)30428-5. doi: 10.1016/j.euroneuro.2017.07.001. [Epub ahead of print]
Hartman J, Härmark L, van Puijenbroek E. A global view of undergraduate education in pharmacovigilance. European Journal of Clinical Pharmacology. 2017;1-9. Available from, DOI: 10.1007/s00228-017-2237-z
Hazen ACM, de Bont AA, Boelman L, Zwart DLM, de Gier JJ, de Wit NJ, Bouvy ML. The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: A systematic review. Research in Social and Administrative Pharmacy. DOI: 10.1016/j.sapharm.2017.04.014
Heisen M, Treur MJ, Heemstra HE, Giesen EBW, Postma MJ. Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands. Journal of Medical Economics 2017: 1-27. DOI: 10.1080/13696998.2017.1331912
Holvast F, van Hattem BA, Sinnige J, Schellevis F, Taxis K, Burger H et al. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study. Family practice. 2017 Mar 23. Available from, DOI: 10.1093/fampra/cmx018
Ivanova SA, Osmanova DZ, Boiko AS, Pozhidaev IV, Freidin MB, Fedorenko OY, Semke AV, Bokhan NA, Kornetova EG, Rakhmazova LD, Wilffert B, Loonen A. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics. Schizophrenia Research 2017;182:110-14
Ivanova SA, Osmanova DZ, Freidin MB, Fedorenko OY, Boiko AS, Pozhidaev IV, Semke AV, Bokhan NA, Agarkov AA, Wilffert B, Loonen AJ. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia. World J Biol Psychiatry. 2017 Apr;18(3):239-46
Jacobs MS, van Leent MWJ, Tieleman RG, Jansman FGA, Cao Q, Postma MJ, van Hulst M. Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands. J Med Econ. 2017 Aug 2:1-16. doi: 10.1080/13696998.2017.1363766. [Epub ahead of print]
Jessurun N, van Puijenbroek EP, Otten LS, Mikes O, Vermeulen Windsant A, van Marum RJ et al. Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels - a review of routine practice. British Journal of Clinical Pharmacology. 2017 Jan 29. Available from, DOI: 10.1111/bcp.13201
Kamp J, Bolhuis MS, Tiberi S, Akkerman OW, Centis R, de Lange WC, Kosterink JG, van der Werf TS, Migliori GB, Alffenaar JC.Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis. International journal of antimicrobial agents. 2017 Apr 4. Available from, DOI: 10.1016/j.ijantimicag.2017.01.017
Kamusheva M, Dimitrova M, van Boven JFM, Postma MJ, van der Molen T, Kocks JWH,Mitov K, Doneva M, Petrova D, Georgiev O, Petkova V, Petrova G.Clinical characteristics, treatment patterns and socio-economic burden of COPD in Bulgaria. Journal of Medical Economics. 2017 Jan 23. Available from, DOI: 10.1080/13696998.2017.1279620
Kibbelaar RE, Oortgiesen BE, van der Wal-Oost AM, Boslooper K, Coebergh JW, Veeger NJGM, Joosten P, Storm H, van Roon EN, Hoogendoorn M. Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology. Eur J Cancer. 2017 Oct 6;86:178-185. doi: 10.1016/j.ejca.2017.09.007. [Epub ahead of print]
Kollef MH, Bassetti M, Francois B, Burnham J, Dimopoulos G, Garnacho-Montero J, Lipman J, Luyt CE, Nicolau DP, Postma MJ, Torres A, Welte T, Wunderink RG.The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Medicine. 2017 Feb 4;1-11. Available from, DOI: 10.1007/s00134-017-4682-7
Kovačević SV, Miljković B, Ćulafić M, Kovačević M, Golubović B, Jovanović M, Vučićević K, de Gier JJ. Evaluation of drug-related problems in older polypharmacy primary care patients. Journal of Evaluation in Clinical Practice. 2017 DOI: 10.1111/jep.12737
Kovačević SV, Miljković B, Vučićević K, Ćulafić M, Kovačević M, Golubović B, Jovanović M, de Gier JJ. Elderly polypharmacy patients' needs and concerns regarding medication assessed using the structured patient-pharmacist consultation model. Patient Education and Counseling. 2017 DOI: 10.1016/j.pec.2017.05.001
Loonen AJM, Ivanova SA. Circuits regulating pleasure and happiness: evolution and role in mental disorders. Acta Neuropsychiatr. 2017 May 5:1-14. doi: 10.1017/neu.2017.8. [Epub ahead of print]
Loonen A, Kupka R, Ivanova SA. Circuits Regulating Pleasure and Happiness in Bipolar Disorder. Frontiers in Neural Circuits 2017;11(35):1-15. DOI: 10.3389/fncir.2017.00035
Loonen AJM, Ivanova SA. Commentary on "A non-reward attractor theory of depression": A proposal to include the habenula connection. Neuroscience and Biobehavioral Reviews. 2017 DOI: 10.1016/j.neubiorev.2017.02.007
Medic G, Korchagina D, Young KE, Toumi M, Postma MJ, Wille M, Hemels M. Do payers value rarity?: An analysis of the relationship between disease rarity and orphan drug prices in Europe. Journal of market access & health policy. 2017;5(1):1299665. Available from, DOI: 10.1080/20016689.2017.1299665
Mihajlović J, Bax P, van Breugel E, Blommestein HM, Hoogendoorn M, Hospes W, Postma MJ. Microcosting Study of Rituximab Subcutaneous Injection Versus Intravenous Infusion. Clinical Therapeutics 2017;39(6):1221-32 .e4. DOI: 10.1016/j.clinthera.2017.05.342
Nguyen T, Le KK, Cao HTK, Tran DTT, Ho LM, Thai TND, Pham HTK, Pham PT, Nguyen TH, Hak E, Pham TT, Taxis K. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study. BMJ Open. 2017 Oct 5;7(10):e017008. doi: 10.1136/bmjopen-2017-017008
Nguyen TPL, Schuiling-Veninga CCM, Nguyen TBY, Vu T-H, Wright EP, Postma MJ.Adherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community. PLoS ONE. 2017;12(2):e0171203. Available from, DOI: 10.1371/journal.pone.0171203
Nuntamool N, Ngamsamut N, Vanwong N, Puangpetch A, Chamnanphon M, Hongkaew Y, Limsila P, Suthisisang C, Wilffert B, Sukasem C.Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents. Basic & clinical pharmacology & toxicology. 2017. Available from, DOI: 10.1111/bcpt.12803
Oortgiesen BE, van Roon EN, Joosten P, Kibbelaar RE, Storm H, Hovenga S et al.The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study. European Journal of Clinical Pharmacology. 2017. Available from, DOI: 10.1007/s00228-017-2227-1
Ramaekers BLT, Riemsma R, Tomini F, van Asselt T, Deshpande S, Duffy S, Armstrong N, Severens JL, Kleijnen J, Joore MA.Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal". Pharmacoeconomics. 2017 Jun;35(6):665-667. doi: 10.1007/s40273-017-0507-3
Rochanathimoke O, Riewpaiboon A, Postma MJ, Thinyounyong W, Thavorncharoensap M. Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct 6:1-8. doi: 10.1080/14737167.2018.1386561. [Epub ahead of print]
Rolfes L, van Hunsel F, van der Linden L, Taxis K, van Puijenbroek E. The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis. Drug Safety. 2017 Apr 12. Available from, DOI: 10.1007/s40264-017-0530-5
Sabblah GT, Darko DM, Mogtari H, Härmark L, van Puijenbroek E. 'Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana. Drug Safety. DOI: 10.1007/s40264-017-0563-9
Sanders LMJ, Hortobágyi T, van Staveren G, Taxis K, Boersma F, Klein HC, Bossers WJR, Blankevoort CG, Scherder EJA, van der Zee EA, van Heuvelen MJG. Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia. European Journal of Clinical Pharmacology 2017doi: 10.1007/s00228-017-2319-y. [Epub ahead of print]
Schey C, Krabbe PFM, Postma MJ, Connolly MP. Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs. Orphanet journal of rare diseases. 2017 Jan 17;12(1). 10. Available from, DOI: 10.1186/s13023-016-0555-3
Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rolfes L, van Puijenbroek EP,Richir MC, van Agtmael MA.Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study. Drug Safety. 2017 Jan 25. Available from, DOI: 10.1007/s40264-016-0502-1
Setiawan D, Luttjeboer J, Pouwels KB, Wilschut JC, Postma MJ.Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis. Japanese journal of clinical oncology. 2017 Jan 1. Available from, DOI: 10.1093/jjco/hyw192
Setiawan D, Oktora MP, Hutubessy R, Riewpaiboon A, Postma MJ. The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review. Expert Rev Vaccines. 2017 Jul 28:1-11. doi: 10.1080/14760584.2017.1357472. [Epub ahead of print]
Stuijt CCM, vd Bemt B, Boerlage VE, Taxis K, Karapinar F. Determinants for medication reconciliation interventions on hospital admission and discharge: An observational multi-centre study. European Journal of Internal Medicine 2017pii: S0953-6205(17)30332-1. doi: 10.1016/j.ejim.2017.09.001. [Epub ahead of print]
Taxis K, Kochen S, Wouters H, Boersma F, Jan Gerard M, Mulder H, Pavlovic J, Stevens G, McLachlan A, Pont LG. Cross-national comparison of medication use in Australian and Dutch nursing homes. Age Ageing 2017 Mar 1;46(2):320-3 doi: 10.1093/ageing/afw218
ter Avest M, Veringa A, van den Heuvel ER, Kosterink J, Scholvinck EH, Tissing WJE, Alffenaar J-WC. The effect of inflammation on voriconazole trough concentrations in children. British Journal of Clinical Pharmacology 2017;83(3): 678-80. DOI: 10.1111/bcp.13151, 10.1111/bcp.13151
Terkola R, Antoñanzas F, Postma M. Economic evaluation of personalized medicine: a call for real-world data. European Journal of Health Economics. 2017 Apr 5. Available from, DOI: 10.1007/s10198-017-0890-x
Tran YH, Groen H, Bergman JE, Hak E, Wilffert B. Exposure to reactive intermediate-inducing drugs during pregnancy and the incident use of psychotropic medications among children. Pharmacoepidemiol Drug Saf. 2017 Jan 18. doi: 10.1002/pds.4161
Tran Y-H, Schuiling-Veninga CCM, Bergman JEH, Groen H, Wilffert B. Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study. Cns Drugs 2017 Jun;31(6):483-93. DOI: 10.1007/s40263-017-0436-x
van Altena R, Dijkstra JA, van der Meer ME, Borjas Howard JF, Kosterink JGW, van Soolingen D,van der Werf TS, Alffenaar JW.Reduced chance of hearing loss associated with Therapeutic Drug Monitoring of Aminoglycosides in the treatment of Multidrug Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 2017 Jan 9. Available from, DOI: 10.1128/AAC.01400-16
van der Elst KC, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, Uges DR, Touw DJ, Kosterink JG, van der Werf TS, Alffenaar JC.Low Caspofungin Exposure in Patients in Intensive Care Units. Antimicrobial Agents and Chemotherapy. 2017 Feb;61(2). ARTN e01582-16. Available from, DOI: 10.1128/AAC.01582-16
van der Paardt AL, Akkerman OW, Gualano G, Palmieri F, Davies Forsman L, Aleksa A, Tiberi S, de Lange WC, Bolhuis MS, Skrahina A, van Soolingen D, Kosterink JG, Migliori GB, van der Werf TS, Alffenaar JC.Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. European Respiratory Journal. 2017;49(3). Available from, DOI: 10.1183/13993003.01612-2016
van der Pol S, Degener F, Postma MJ, Vemer P. An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands. Value Health 2017 Mar;20(3):388-396. doi: 10.1016/j.jval.2016.10.015. Epub 2016 Dec 22
van der Schans J, Çiçek R, de Vries TW, Hak E, Hoekstra PJ. Association of atopic diseases and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses. Neuroscience and Biobehavioral Reviews. 2017;74(Pt A):139-148. Available from, DOI: 10.1016/j.neubiorev.2017.01.011
van der Schans J, Çiçek R, Vardar S, Bos JH, de Vries TW, Hoekstra PJ, Hak E. Methylphenidate use and school performance among primary school children: a descriptive study. BMC Psychiatry. 2017;17(1):116. Available from, DOI: 10.1186/s12888-017-1279-1
van der Schans J, Aikman B, de Vries TW, Hoekstra PJ, Hak E. Association Between Attention-Deficit/Hyperactivity Disorder and Asthma Among Adults: A Case-Control Study. Chest 2017;151(6):1406-07. DOI: 10.1016/j.chest.2017.03.052
van der Schans S, Goossens LMA, Boland MRS, Kocks JWH, Postma MJ, van Boven JFM,Rutten-van Mölken MP.Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations. Pharmacoeconomics. 2017 Jan 3;35(1):43-63. Available from, DOI: 10.1007/s40273-016-0448-2
van der Veen W, van den Bemt PM, Bijlsma M, de Gier HJ, Taxis K. Association Between Workarounds and Medication Administration Errors in Bar Code-Assisted Medication Administration: Protocol of a Multicenter Study. JMIR research protocols . 2017 Apr 28;6(4):e74. Available from, DOI: 10.2196/resprot.7060
van Doorn E, Pleguezuelos O, Liu H, Fernandez A, Bannister R, Stoloff G, Oftung F, Norley S, Huckriede A, Frijlink HW, Hak E.Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial. BMC Infectious Diseases. 2017 Apr 4;17(1):241. Available from, DOI: 10.1186/s12879-017-2341-9
van Doorn E, Liu H, Ben-Yedidia T, Hassin S, Visontai I, Norley S, Frijlink HW, Hak E.Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol. Medicine. 2017;96(11):p e6339. Available from, DOI: 10.1097/MD.0000000000006339
van Doorn E, Darvishian M, Dijkstra F, Donker GA, Overduin P, Meijer A. Hak E. Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups. Vaccine. 2017;35(21):2831-2839. Available from, DOI: 10.1016/j.vaccine.2017.04.012
van Gelder MMHJ, Vorstenbosch S, Derks L, Winkel BT, van Puijenbroek EP, Roeleveld N. Web-based questionnaires to assess perinatal outcome proved to be valid. J Clin Epidemiol. 2017 Jul 17. pii: S0895-4356(16)30652-7. doi: 10.1016/j.jclinepi.2017.07.004. [Epub ahead of print]
Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Biesen WV, Zoccali C, European Kidney Health Alliance. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30
Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Van Biesen W, Zoccali C, European Kidney Health Alliance. Further approaches to reduce the cost of renal replacement therapy. Nat Rev Nephrol. 2017 Sep 25. doi: 10.1038/nrneph.2017.136. [Epub ahead of print]
van Hulst M, Stevanovic J, Jacobs MS, Tieleman RG, Kappelhoff B, Postma MJ. The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands. J Med Econ. 2017 Aug 24:1-21. doi: 10.1080/13696998.2017.1372222. [Epub ahead of print]
van Leeuwen RWF, Jansman FGA, Hunfeld NG, Peric R, Reyners AKL, Imholz ALT et al.Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options. Clinical Pharmacokinetics. 2017 Jan 18. Available from, DOI: 10.1007/s40262-016-0503-3
van Maanen BM, de Boer P, Dolk FCK, Friedrich AW, Wilschut JC, Pitman R,Postma MJ.Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza control. Expert review of vaccines. 2017 Jan;16(1):1-4. Available from, DOI: 10.1080/14760584.2016.1221347
van Rijn SP, Zuur MA, van Altena R, Akkerman OW, Proost JH, de Lange WCM,Kerstjens HA, Touw DJ, van der Werf TS, Kosterink JG, Alffenaar JW.Pharmacokinetic Modeling and Limited Sampling Strategies based on healthy volunteers for Monitoring of Ertapenem in MDR-TB patients. Antimicrobial Agents and Chemotherapy. 2017 Jan 30. Available from, DOI: 10.1128/AAC.01783-16
Van't Boveneind-Vrubleuskaya N, Seuruk T, van Hateren K, van der Laan T, Kosterink JGW, van der Werf TS, van Soolingen D, van den Hof S, Skrahina A, Alffenaar J-WC. Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis patients. Antimicrobial Agents and Chemotherapy. DOI: 10.1128/AAC.00343-17
Veringa A, ter Avest M, Span LFR, van den Heuvel ER, Touw DJ, Zijlstra JG, Kosterink JG, van der Werf TS, Alffenaar JC.Voriconazole metabolism is influenced by severe inflammation: a prospective study. Journal of Antimicrobial Chemotherapy. 2017 Jan;72(1):261-267. Available from, DOI: 10.1093/jac/dkw349
Veringa A, Geling S, Span LFR, Vermeulen KM, Zijlstra JG, van der Werf TS, Kosterink JG, Alffenaar JC.Bioavailability of voriconazole in hospitalised patients.International journal of antimicrobial agents. 2017 Feb;49(2):243-246. Available from, DOI: 10.1016/j.ijantimicag.2016.10.010
Warnders F-J, Terwisscha van Scheltinga AG, Knuehl C, van Roy M, de Vries EF, Kosterink JGW, de Vries EG, Lub-de Hooge MN.HER3 specific biodistribution and tumor uptake of (89)Zr-MSB0010853 visualized by real-time and non-invasive PET imaging. Journal of Nuclear Medicine. 2017 Mar 30. Available from, DOI: 10.2967/jnumed.116.181586
Wouters H, van der Meer H, Taxis K. Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies. European Journal of Clinical Pharmacology. 2017 Mar;73(3):257-266. Available from, DOI: 10.1007/s00228-016-2162-6
Zakiyah N, van Asselt AD, Postma MJ. Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis. J Med Econ. 2017 Mar;20(3):280-7. doi: 10.1080/13696998.2016.1254090. Epub 2016 Nov 11.
Alting EK, Riphagen LM, Schuiling-Veninga CCM, Brouwers JRBJ, Woerdenbag H. Is er een plaats voor voedingsmiddelen verrijkt met fytosterolen bij cardiovasculair risicomanagement? Kritische analyse van de bewijskracht voor cholesterolverlaging. Nederlands Platform voor Farmaceutisch Onderzoek. 2017;2:1-13. A 1641
Brouwers JRBJ, Sleeboom HP. Osteoporose en pillen, een ongemakkelijke combinatie. In Dit Verband 2017;27(3)14-15

Brouwers JRBJ, Nieboer P, Wilffert B. Metformine: ondanks hoge leeftijd nog springlevend. Pharmaceutisch Weekblad 2017;152(37):10-3

Hak, E. Klinische farmaco-epidemiologie nuttig bij oordeel over profylaxe. Pharmaceutisch Weekblad 2017;152(16):20-2
van Doorn E, Darvishian M, Dijkstra F, Bijlsma MJ, Donker GA, de Lange MMA, Cadenau LM, Hak E, Meijer A. Effectiviteit van influenzavaccinatie in Nederland. Nederlands tijdschrift voor geneeskunde 2017;161(0):1648
Wilffert B. Genotypering VKORC1 en CYP2C9 bij dosering van acenocoumarol en fenprocoumon. Pharmaceutische Weekblad Wetenschappelijk Platform 2017;152(19): e1637a
Laatst gewijzigd:13 oktober 2017 09:21